rss
J Clin Pathol doi:10.1136/jcp.2006.041731

Basal-like breast cancer

  1. Leonard Da Silva (leonardd{at}qimr.edu.au)
  1. Molecular and Cellular Pathology, School of Medicine, The University of Queensland, Australia
    1. Catherine Clarke (catherine.clarke{at}qimr.edu.au)
    1. Molecular and Cellular Pathology, School of Medicine, The University of Queensland, Australia
      1. Sunil R Lakhani (s.lakhani{at}uq.edu.au)
      1. Molecular and Cellular Pathology, School of Medicine, The University of Queensland, Australia
        • Published Online First 11 May 2007

        Abstract

        "Basal" breast cancers are dominating the breast research literature at present and pathologists are under increasing pressure to evaluate for such a phenotype by their surgical and oncological colleagues. Yet, there is also much confusion about how to assess cancers, which immunohistochemical markers to use, what meaning and benefit this provides and what the surgeons and oncologists will do with the information. Much remains to be done to answer all these questions but here we try to shed light on some of the issues and suggest what is still to come.

        Latest from JCP Education

        Latest from JCP Education

        Register for free content


        Free sample
        This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of JCP.
        View free sample issue >>

        Free archive
        The full back archive is now available for JCP. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
        Register to access the free archive >>

        Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

      1. Latest Pathology jobs

        Latest Pathology jobs